{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:22:07Z","timestamp":1788355327985,"version":"build-2803163510"},"reference-count":124,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union\u2013NextGenerationEU","award":["PNRR-M4C2-I1.3 Project PE_00000019"],"award-info":[{"award-number":["PNRR-M4C2-I1.3 Project PE_00000019"]}]},{"name":"European Union\u2013NextGenerationEU","award":["CUP E93C22001860006"],"award-info":[{"award-number":["CUP E93C22001860006"]}]},{"name":"Ministry of University and Research","award":["PNRR-M4C2-I1.3 Project PE_00000019"],"award-info":[{"award-number":["PNRR-M4C2-I1.3 Project PE_00000019"]}]},{"name":"Ministry of University and Research","award":["CUP E93C22001860006"],"award-info":[{"award-number":["CUP E93C22001860006"]}]},{"DOI":"10.13039\/501100000780","name":"HEAL ITALIA","doi-asserted-by":"publisher","award":["PNRR-M4C2-I1.3 Project PE_00000019"],"award-info":[{"award-number":["PNRR-M4C2-I1.3 Project PE_00000019"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"HEAL ITALIA","doi-asserted-by":"publisher","award":["CUP E93C22001860006"],"award-info":[{"award-number":["CUP E93C22001860006"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Liver transplantation represents a chief therapeutic approach for acute liver failure, end-stage liver disease and hepatocellular carcinoma. Despite witnessing advancements in short- and medium-term survival over recent decades, attributed to refinements in surgical techniques and immunosuppressive protocols, long-term mortality remains impervious to modification. Notably, cardiovascular disease emerges as a predominant cause of mortality among liver transplant recipients. This trend is accentuated by the increasing prominence of non-alcoholic steatohepatitis-related cirrhosis as an indication for liver transplantation. Moreover, the administration of immunosuppressive agents is intricately linked to the degradation of the metabolic profile in liver transplant recipients, thereby contributing to the initiation or exacerbation of cardiovascular risk factors, such as hypertension, diabetes, and dyslipidaemia. In addition, the post-liver transplantation period is marked by a decline in lifestyle quality and a failure to acknowledge the psychological distress experienced by patients throughout the transplant process. These factors can precipitate a deterioration in the patient\u2019s metabolic profile, exacerbated by suboptimal therapeutic compliance. This narrative review aims to comprehensively address the principal metabolic disorders intricately associated with liver transplantation.<\/jats:p>","DOI":"10.3390\/jcm13041014","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T11:42:05Z","timestamp":1707478925000},"page":"1014","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Metabolic Disorders in Liver Transplant Recipients: The State of the Art"],"prefix":"10.3390","volume":"13","author":[{"given":"Filippo","family":"Gabrielli","sequence":"first","affiliation":[{"name":"Internal and Metabolic Medicine, Department of Medical and Surgical Sciences for Children & Adults, AOU di Modena, University of Modena and Reggio Emilia, 41126 Modena, Italy"},{"name":"Department of Surgical Sciences, University of Bologna, 40126 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Golfieri","sequence":"additional","affiliation":[{"name":"Clinical Psychology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant\u2019Orsola, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Nascimbeni","sequence":"additional","affiliation":[{"name":"Internal and Metabolic Medicine, Department of Medical and Surgical Sciences for Children & Adults, AOU di Modena, University of Modena and Reggio Emilia, 41126 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4794-9809","authenticated-orcid":false,"given":"Pietro","family":"Andreone","sequence":"additional","affiliation":[{"name":"Internal and Metabolic Medicine, Department of Medical and Surgical Sciences for Children & Adults, AOU di Modena, University of Modena and Reggio Emilia, 41126 Modena, Italy"},{"name":"Postgraduate School of Allergology and Clinical Immunology, University of Modena and Reggio Emilia, 41126 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8042-6508","authenticated-orcid":false,"given":"Stefano","family":"Gitto","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"10263","DOI":"10.3389\/ti.2022.10263","article-title":"Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort","volume":"35","author":"Serrano","year":"2022","journal-title":"Transpl. Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1432-2277.2007.00596.x","article-title":"Long-Term Results after Liver Transplantation","volume":"21","author":"Pfitzmann","year":"2008","journal-title":"Transpl. Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1432-2277.2005.00215.x","article-title":"The First One Thousand Liver Transplants in Turin: A Single-Center Experience in Italy","volume":"18","author":"Salizzoni","year":"2005","journal-title":"Transpl. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1600-6143.2010.03126.x","article-title":"Evolution of Causes and Risk Factors for Mortality Post-Liver Transplant: Results of the NIDDK Long-Term Follow-up Study","volume":"10","author":"Watt","year":"2010","journal-title":"Am. J. Transplant."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/TP.0000000000002113","article-title":"Gender, Race and Disease Etiology Predict De Novo Malignancy Risk After Liver Transplantation: Insights for Future Individualized Cancer Screening Guidance","volume":"103","author":"Bhat","year":"2019","journal-title":"Transplantation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index","volume":"6","author":"Feng","year":"2006","journal-title":"Am. J. Transplant."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kwong, A.J., Ebel, N.H., Kim, W.R., Lake, J.R., Smith, J.M., Schladt, D.P., Schnellinger, E.M., Handarova, D., Weiss, S., and Cafarella, M. (2024, January 22). OPTN\/SRTR 2021 Annual Data Report: Liver, Available online: https:\/\/srtr.transplant.hrsa.gov\/annual_reports\/2021\/Liver.aspx.","DOI":"10.1016\/j.ajt.2023.02.006"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/hep4.1915","article-title":"Nonalcoholic Steatohepatitis Is the Most Common Indication for Liver Transplantation among the Elderly: Data from the United States Scientific Registry of Transplant Recipients","volume":"6","author":"Stepanova","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: Results from a Nationwide Cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver Fibrosis, but No Other Histologic Features, Is Associated with Long-Term Outcomes of Patients with Nonalcoholic Fatty Liver Disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients with Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study","volume":"155","author":"Castellanos","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Haflidadottir, S., Jonasson, J.G., Norland, H., Einarsdottir, S.O., Kleiner, D.E., Lund, S.H., and Bj\u00f6rnsson, E.S. (2014). Long-Term Follow-up and Liver-Related Death Rate in Patients with Non-Alcoholic and Alcoholic Related Fatty Liver Disease. BMC Gastroenterol., 14.","DOI":"10.1186\/1471-230X-14-166"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep4.1134","article-title":"Natural History of Nonalcoholic Fatty Liver Disease: A Prospective Follow-up Study with Serial Biopsies","volume":"2","author":"Nasr","year":"2018","journal-title":"Hepatol. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis Stage but Not NASH Predicts Mortality and Time to Development of Severe Liver Disease in Biopsy-Proven NAFLD","volume":"67","author":"Nasr","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Mak, L.-Y., Chan, A.C., Wong, T.C., Dai, W.-C., She, W.-H., Ma, K.-W., Sin, S.-L., Chu, K.-W., Seto, W.-K., and Yuen, M.-F. (2023). High Prevalence of de Novo Metabolic Dysfunction-Associated Fatty Liver Disease after Liver Transplantation and the Role of Controlled Attenuation Parameter. BMC Gastroenterol., 23.","DOI":"10.1186\/s12876-023-02940-y"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gitto, S., Golfieri, L., Gabrielli, F., Falcini, M., Sofi, F., Tam\u00e8, M.R., De Maria, N., Marzi, L., Mega, A., and Valente, G. (2023). Physical Activity in Liver Transplant Recipients: A Large Multicenter Study. Intern. Emerg. Med.","DOI":"10.21203\/rs.3.rs-3184704\/v1"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jceh.2023.03.013","article-title":"NASH After Liver Transplantation: Impact of Immunosuppression","volume":"13","author":"Taneja","year":"2023","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_18","first-page":"165937","article-title":"Hypertension: The Neglected Complication of Transplantation","volume":"2013","author":"Aparicio","year":"2013","journal-title":"Int. Sch. Res. Not."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/LVT.0000000000000004","article-title":"De Novo Metabolic Syndrome after Liver Transplantation: A Meta-Analysis on Cumulative Incidence, Risk Factors, and Outcomes","volume":"29","author":"Lim","year":"2023","journal-title":"Liver Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1590\/s0004-2803.202100000-13","article-title":"Prevalence and time of development of systemic arterial hypertension in patients after liver transplantation","volume":"58","author":"Lemos","year":"2021","journal-title":"Arq. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.transproceed.2013.11.047","article-title":"Long-Term Complications after Liver Transplantation","volume":"46","author":"Kuramitsu","year":"2014","journal-title":"Transplant. Proc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.transproceed.2011.03.004","article-title":"Cardiovascular Risk Factors after Liver Transplantation: Analysis of Related Factors","volume":"43","author":"Taybi","year":"2011","journal-title":"Transplant. Proc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1016\/j.transproceed.2011.07.011","article-title":"Arterial Hypertension in Liver Transplant Recipients","volume":"43","author":"Hryniewiecka","year":"2011","journal-title":"Transplant. Proc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/j.1600-6143.2012.04077.x","article-title":"Diabetes, Hypertension and Hyperlipidemia: Prevalence over Time and Impact on Long-Term Survival after Liver Transplantation","volume":"12","author":"Parekh","year":"2012","journal-title":"Am. J. Transplant."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jash.2018.01.002","article-title":"Risk Factors for Arterial Hypertension after Liver Transplantation","volume":"12","author":"Vanni","year":"2018","journal-title":"J. Am. Soc. Hypertens."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.transproceed.2014.10.050","article-title":"Prevalence of Hypertension after Living-Donor Liver Transplantation: A Prospective Study","volume":"47","author":"Tong","year":"2015","journal-title":"Transplant. Proc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.transproceed.2009.02.005","article-title":"Hypertension Induced by Immunosuppressive Drugs: A Comparative Analysis between Sirolimus and Cyclosporine","volume":"41","author":"Reis","year":"2009","journal-title":"Transplant. Proc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-Term Management of the Successful Adult Liver Transplant: 2012 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transplant."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.TP.0000116418.78963.DC","article-title":"Hemodynamic Effects of Amlodipine, Bisoprolol, and Lisinopril in Hypertensive Patients after Liver Transplantation","volume":"77","author":"Neal","year":"2004","journal-title":"Transplantation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/met.2020.0068","article-title":"MEDITRA Research Group Metabolic Disorders After Liver Transplantation","volume":"19","author":"Gitto","year":"2021","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/lt.500030409","article-title":"Hyperlipidemia in Liver Transplant Recipients: Prevalence and Risk Factors","volume":"3","author":"Gisbert","year":"1997","journal-title":"Liver Transplant. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.TP.0000100685.70064.90","article-title":"Is There Disparity between Risk and Incidence of Cardiovascular Disease after Liver Transplant?","volume":"77","author":"Neal","year":"2004","journal-title":"Transplantation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.3748\/wjg.v22.i12.3315","article-title":"Lipids in Liver Transplant Recipients","volume":"22","author":"Kabar","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_34","first-page":"641","article-title":"Rescue Immunosuppression with Mammalian Target","volume":"42","author":"Pulido","year":"2010","journal-title":"of Rapamycin Inhibitor Drugs in Liver Transplantation. Transplant. Proc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/lt.22292","article-title":"Conversion to Everolimus in Maintenance Liver Transplant Patients: A Multicenter, Retrospective Analysis","volume":"17","author":"Saliba","year":"2011","journal-title":"Liver Transplant."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/ki.1996.346","article-title":"ACTH Lowers Serum Lipids in Steroid-Treated Hyperlipemic Patients with Kidney Disease","volume":"50","author":"Berg","year":"1996","journal-title":"Kidney Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0002-9343(88)80234-1","article-title":"Relationship between Corticosteroid Exposure and Plasma Lipid Levels in Heart Transplant Recipients","volume":"85","author":"Becker","year":"1988","journal-title":"Am. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1097\/01.ASN.0000071515.27754.67","article-title":"Improved Cardiovascular Risk Profile and Renal Function in Renal Transplant Patients after Randomized Conversion from Cyclosporine to Tacrolimus","volume":"14","author":"Artz","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_39","first-page":"421","article-title":"Initial Steroid-Free versus Steroid-Based Maintenance Therapy and Steroid Withdrawal after Heart Transplantation: Two Views of the Steroid Question","volume":"11","author":"Keogh","year":"1992","journal-title":"J. Heart Lung Transplant."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/jlts.2001.21289","article-title":"Tacrolimus Conversion Improves Hyperlipidemic States in Stable Liver Transplant Recipients","volume":"7","author":"Manzarbeitia","year":"2001","journal-title":"Liver Transplant."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine versus Tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am. J. Transplant."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"143S","DOI":"10.1016\/S0041-1345(03)00233-1","article-title":"Sirolimus Changes Lipid Concentrations and Lipoprotein Metabolism in Kidney Transplant Recipients","volume":"35","author":"Morrisett","year":"2003","journal-title":"Transplant. Proc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/embor.2013.5","article-title":"The Multifaceted Role of mTORC1 in the Control of Lipid Metabolism","volume":"14","author":"Ricoult","year":"2013","journal-title":"EMBO Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/ndt\/gfr238","article-title":"Effect of Different Immunosuppressive Regimens on the Evolution of Distinct Metabolic Parameters: Evidence from the Symphony Study","volume":"27","author":"Claes","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/ajt.12852","article-title":"Risk of Metabolic Complications in Kidney Transplantation after Conversion to mTOR Inhibitor: A Systematic Review and Meta-Analysis","volume":"14","author":"Murakami","year":"2014","journal-title":"Am. J. Transplant."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1034\/j.1600-6143.2002.20902.x","article-title":"Cardiovascular Toxicities of Immunosuppressive Agents","volume":"2","author":"Miller","year":"2002","journal-title":"Am. J. Transplant."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"European Association for The Study of the Liver (2016). EASL Clinical Practice Guidelines: Liver Transplantation. J. Hepatol., 64, 433\u2013485.","DOI":"10.1016\/j.jhep.2015.10.006"},{"key":"ref_48","unstructured":"Authors\/Task Force Members, and ESC Committee for Practice Guidelines (CPG) (2019). ESC National Cardiac Societies 2019 ESC\/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk. Atherosclerosis, 290, 140\u2013205."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.0000151805.86933.35","article-title":"Drug Therapy in the Heart Transplant Recipient: Part IV: Drug-Drug Interactions","volume":"111","author":"Page","year":"2005","journal-title":"Circulation"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.2174\/138161206779026308","article-title":"Statins and Solid Organ Transplantation","volume":"12","author":"Gazi","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/TP.0b013e318198d7d0","article-title":"The Efficacy and Tolerability of Ezetimibe in Cardiac Transplant Recipients Taking Cyclosporin","volume":"87","author":"Shaw","year":"2009","journal-title":"Transplantation"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/lt.21710","article-title":"Safety and Effectiveness of Ezetimibe in Liver Transplant Recipients with Hypercholesterolemia","volume":"15","author":"Almutairi","year":"2009","journal-title":"Liver Transplant."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jacc.2018.04.054","article-title":"The Evolving Future of PCSK9 Inhibitors","volume":"72","author":"Rosenson","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jaccas.2019.09.026","article-title":"Use of PCSK9 Inhibitors in Solid Organ Transplantation Recipients","volume":"2","author":"Warden","year":"2020","journal-title":"JACC Case Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.numecd.2013.05.002","article-title":"Managing the Residual Cardiovascular Disease Risk Associated with HDL-Cholesterol and Triglycerides in Statin-Treated Patients: A Clinical Update","volume":"23","author":"Reiner","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0168-8278(00)80065-3","article-title":"Prevalence of Diabetes Mellitus in Patients with End-Stage Liver Cirrhosis Due to Hepatitis C, Alcohol, or Cholestatic Disease","volume":"32","author":"Zein","year":"2000","journal-title":"J. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jhep.2018.02.004","article-title":"Recipient Characteristics and Morbidity and Mortality after Liver Transplantation","volume":"69","author":"Asrani","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cgh.2013.09.023","article-title":"Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis","volume":"12","author":"Wang","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41574-018-0137-7","article-title":"Post-Transplant Diabetes Mellitus in Patients with Solid Organ Transplants","volume":"15","author":"Jenssen","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(09)60553-5","article-title":"Stress Hyperglycaemia","volume":"373","author":"Dungan","year":"2009","journal-title":"Lancet"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2021). 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes\u20142021. Diabetes Care, 44, S211\u2013S220.","DOI":"10.2337\/dc21-S015"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/ajt.12850","article-title":"Proceedings from an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions","volume":"14","author":"Sharif","year":"2014","journal-title":"Am. J. Transplant."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Liu, F.-C., Lin, J.-R., Chen, H.-P., Tsai, Y.-F., and Yu, H.-P. (2016). Prevalence, Predictive Factors, and Survival Outcome of New-Onset Diabetes after Liver Transplantation: A Population-Based Cohort Study. Medicine, 95.","DOI":"10.1097\/MD.0000000000003829"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/apt.12881","article-title":"The Impact of Type 2 Diabetes and Obesity on the Long-Term Outcomes of More than 85 000 Liver Transplant Recipients in the US","volume":"40","author":"Younossi","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/TP.0000000000003867","article-title":"Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients","volume":"106","author":"Brodosi","year":"2022","journal-title":"Transplantation"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/ajt.14401","article-title":"Sustained Posttransplantation Diabetes Is Associated with Long-Term Major Cardiovascular Events Following Liver Transplantation","volume":"18","author":"Roccaro","year":"2018","journal-title":"Am. J. Transplant."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/lt.20439","article-title":"New-Onset Diabetes after Liver Transplantation: From Pathogenesis to Management","volume":"11","author":"Marchetti","year":"2005","journal-title":"Liver Transplant."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/lt.21010","article-title":"Risk Factors for New-Onset Diabetes Mellitus Following Liver Transplantation and Impact of Hepatitis C Infection: An Observational Multicenter Study","volume":"13","author":"Saliba","year":"2007","journal-title":"Liver Transplant."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature05097","article-title":"Calcineurin\/NFAT Signalling Regulates Pancreatic Beta-Cell Growth and Function","volume":"443","author":"Heit","year":"2006","journal-title":"Nature"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/ajt.12236","article-title":"The Higher Diabetogenic Risk of Tacrolimus Depends on Pre-Existing Insulin Resistance: A Study in Obese and Lean Zucker Rats","volume":"13","author":"Porrini","year":"2013","journal-title":"Am. J. Transplant."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Odenwald, M.A., Roth, H.F., Reticker, A., Segovia, M., and Pillai, A. (2023). Evolving Challenges with Long-Term Care of Liver Transplant Recipients. Clin. Transplant., 37.","DOI":"10.1111\/ctr.15085"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2022). 6. Glycemic Targets: Standards of Medical Care in Diabetes\u20142022. Diabetes Care, 45, S83\u2013S96.","DOI":"10.2337\/dc22-S006"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1210\/jc.2012-1267","article-title":"Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis","volume":"97","author":"Zhang","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.trre.2016.09.001","article-title":"Drug-Drug Interactions between Immunosuppressants and Antidiabetic Drugs in the Treatment of Post-Transplant Diabetes Mellitus","volume":"31","author":"Vanhove","year":"2017","journal-title":"Transplant. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/15269248231189880","article-title":"Safety and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Solid Organ Transplant Recipients","volume":"33","author":"Sweiss","year":"2023","journal-title":"Prog. Transplant."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"100729","DOI":"10.1016\/j.trre.2022.100729","article-title":"Use of Sodium-Glucose Co-Transporter 2 Inhibitors in Solid Organ Transplant Recipients with Pre-Existing Type 2 or Post-Transplantation Diabetes Mellitus: A Systematic Review","volume":"37","author":"Lin","year":"2023","journal-title":"Transplant. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1592\/phco.30.5.463","article-title":"Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus","volume":"30","author":"Neumiller","year":"2010","journal-title":"Pharmacotherapy"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3803\/EnM.2016.31.1.161","article-title":"Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot Study","volume":"31","author":"Bae","year":"2016","journal-title":"Endocrinol. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"494","DOI":"10.6002\/ect.2013.0018","article-title":"Sitagliptin Might Be a Favorable Antiobesity Drug for New Onset Diabetes after a Renal Transplant","volume":"11","author":"Soliman","year":"2013","journal-title":"Exp. Clin. Transplant."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21037\/tgh.2020.02.07","article-title":"Metabolic Syndrome Following Liver Transplantation in Nonalcoholic Steatohepatitis","volume":"6","author":"Spiritos","year":"2021","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"ref_81","first-page":"e285","article-title":"Diagnosis and Management of the Metabolic Syndrome","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Yang, C., Jia, X., Wang, Y., Fan, J., Zhao, C., Yang, Y., and Shi, X. (2022). Trends and Influence Factors in the Prevalence, Intervention, and Control of Metabolic Syndrome among US Adults, 1999\u20132018. BMC Geriatr., 22.","DOI":"10.1186\/s12877-022-03672-6"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.22198","article-title":"Metabolic Syndrome in Liver Transplant Recipients: Prevalence, Risk Factors, and Association with Cardiovascular Events","volume":"17","author":"Laish","year":"2011","journal-title":"Liver Transplant."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/lt.24176","article-title":"Cardiovascular Diseases after Liver Transplantation\u2014A Still Emerging and Unsolved Problem!","volume":"21","author":"Graziadei","year":"2015","journal-title":"Liver Transplant."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/CLD.0000000000000040","article-title":"Management of Metabolic Syndrome after Liver Transplant","volume":"21","author":"Dadlani","year":"2023","journal-title":"Clin. Liver Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A New Definition for Metabolic Dysfunction-Associated Fatty Liver Disease: An International Expert Consensus Statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4254\/wjh.v13.i12.1991","article-title":"De Novo and Recurrence of Metabolic Dysfunction-Associated Fatty Liver Disease after Liver Transplantation","volume":"13","author":"Han","year":"2021","journal-title":"World J. Hepatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"100668","DOI":"10.1016\/j.jhepr.2022.100668","article-title":"Inevitability of Disease Recurrence after Liver Transplantation for NAFLD Cirrhosis","volume":"5","author":"Villeret","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/LVT.0000000000000060","article-title":"Hepatic Steatosis after Liver Transplantation: A Systematic Review and Meta-Analysis","volume":"29","author":"Silva","year":"2023","journal-title":"Liver Transplant."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/TP.0000000000002317","article-title":"Recurrent or De Novo Allograft Steatosis and Long-Term Outcomes After Liver Transplantation","volume":"103","author":"Narayanan","year":"2019","journal-title":"Transplantation"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"7","DOI":"10.20517\/mtod.2022.04","article-title":"Liver Transplantation and Nonalcoholic Steatohepatitis: The State of the Art","volume":"2","author":"Gitto","year":"2022","journal-title":"Metab. Target. Organ. Damage"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s12325-018-0797-7","article-title":"Physical Activity in Liver Transplantation: A Patient\u2019s and Physicians\u2019 Experience","volume":"35","author":"Beekman","year":"2018","journal-title":"Adv. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/j.1600-6143.2006.01391.x","article-title":"A Randomized Trial of Exercise and Dietary Counseling after Liver Transplantation","volume":"6","author":"Krasnoff","year":"2006","journal-title":"Am. J. Transplant."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/lt.500040402","article-title":"Weight Change and Obesity after Liver Transplantation: Incidence and Risk Factors","volume":"4","author":"Everhart","year":"1998","journal-title":"Liver Transplant. Surg."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Nurwanti, E., Uddin, M., Chang, J.-S., Hadi, H., Syed-Abdul, S., Su, E.C.-Y., Nursetyo, A.A., Masud, J.H.B., and Bai, C.-H. (2018). Roles of Sedentary Behaviors and Unhealthy Foods in Increasing the Obesity Risk in Adult Men and Women: A Cross-Sectional National Study. Nutrients, 10.","DOI":"10.3390\/nu10060704"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/lt.23710","article-title":"Physical Activity and Metabolic Syndrome in Liver Transplant Recipients","volume":"19","author":"Kallwitz","year":"2013","journal-title":"Liver Transplant."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000355800","article-title":"Physical Activity in Solid Organ Transplant Recipients: Preliminary Results of the Italian Project","volume":"39","author":"Mosconi","year":"2014","journal-title":"Kidney Blood Press. Res."},{"key":"ref_99","unstructured":"World Health Organization (2024, January 23). WHO Guidelines on Physical Activity and Sedentary Behaviour: At A Glance. Available online: https:\/\/www.who.int\/europe\/publications\/i\/item\/9789240014886."},{"key":"ref_100","first-page":"CD013204","article-title":"Exercise Interventions for Adults after Liver Transplantation","volume":"5","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3748\/wjg.v22.i4.1513","article-title":"Nutrition Therapy: Integral Part of Liver Transplant Care","volume":"22","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nut.2014.05.016","article-title":"Recovery of Nutritional Metabolism after Liver Transplantation","volume":"31","author":"Sugihara","year":"2015","journal-title":"Nutrition"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.clnu.2009.04.019","article-title":"ESPEN ESPEN Guidelines on Parenteral Nutrition: Hepatology","volume":"28","author":"Plauth","year":"2009","journal-title":"Clin. Nutr."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/lt.20894","article-title":"Nutrition for the Liver Transplant Patient","volume":"12","author":"Sanchez","year":"2006","journal-title":"Liver Transplant."},{"key":"ref_105","first-page":"1351","article-title":"Overweight, Obesity and Weight Gain up to Three Years after Liver Transplantation","volume":"27","author":"Correia","year":"2012","journal-title":"Nutr. Hosp."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/lt.23951","article-title":"Weight Gain after Orthotopic Liver Transplantation: Is Nonalcoholic Fatty Liver Disease Cirrhosis a Risk Factor for Greater Weight Gain?","volume":"20","author":"Kouz","year":"2014","journal-title":"Liver Transplant."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Hammad, A., Kaido, T., Aliyev, V., Mandato, C., and Uemoto, S. (2017). Nutritional Therapy in Liver Transplantation. Nutrients, 9.","DOI":"10.3390\/nu9101126"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(22)00122-2","article-title":"Long-Term Secondary Prevention of Cardiovascular Disease with a Mediterranean Diet and a Low-Fat Diet (CORDIOPREV): A Randomised Controlled Trial","volume":"399","author":"Fuentes","year":"2022","journal-title":"Lancet"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ejcn.2017.58","article-title":"Mediterranean Diet and Multiple Health Outcomes: An Umbrella Review of Meta-Analyses of Observational Studies and Randomised Trials","volume":"72","author":"Dinu","year":"2018","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Gitto, S., Golfieri, L., Sofi, F., Tam\u00e8, M.R., Vitale, G., DE Maria, N., Marzi, L., Mega, A., Valente, G., and Borghi, A. (2023). Adherence to Mediterranean Diet in Liver Transplant Recipients: A Cross-Sectional Multicenter Study. Minerva Gastroenterol.","DOI":"10.23736\/S2724-5985.22.03290-9"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.transproceed.2005.06.045","article-title":"Quality-of-Life Assessment Before and After Liver Transplantation","volume":"37","author":"Baccarani","year":"2005","journal-title":"Transplant. Proc."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"101261","DOI":"10.1016\/j.jceh.2023.07.414","article-title":"Psychosocial Assessment and Management-Related Issues Among Liver Transplant Recipients","volume":"14","author":"Varshney","year":"2024","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jhep.2006.10.009","article-title":"Health-Related Quality of Life in Patients with Chronic Hepatitis C and Advanced Fibrosis","volume":"46","author":"Bonkovsky","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.transproceed.2018.02.212","article-title":"Impact of a Multidisciplinary Team on Alcohol Recidivism and Survival After Liver Transplant for Alcoholic Disease","volume":"51","author":"Magistri","year":"2019","journal-title":"Transplant. Proc."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/ajt.12164","article-title":"Early Treatment of Depressive Symptoms and Long-Term Survival After Liver Transplantation","volume":"13","author":"Rogal","year":"2013","journal-title":"Am. J. Transplant."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.aohep.2019.06.011","article-title":"Impact of Psychosocial Status on Liver Transplant Process","volume":"18","author":"Golfieri","year":"2019","journal-title":"Ann. Hepatol."},{"key":"ref_117","first-page":"329","article-title":"Effects of a Support Group Intervention on Physical, Psychological, and Social Adaptation of Liver Transplant Recipients","volume":"14","author":"Ordin","year":"2016","journal-title":"Exp. Clin. Transplant."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.transproceed.2018.02.206","article-title":"Group Psychotherapy Could Improve Depression in Cirrhotic Patients on the Liver Transplant Waiting List","volume":"51","author":"Febrero","year":"2019","journal-title":"Transplant. Proc."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.dld.2023.01.105","article-title":"Group Therapy for Alcohol Addiction Treatment before Liver Transplantation Reduces Post-Transplant Alcohol Relapse: Preliminary Results of a Monocentric Retrospective Study","volume":"55","author":"Costa","year":"2023","journal-title":"Dig. Liver Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7182\/pit2013501","article-title":"Patient-Reported Immunosuppression Nonadherence 6 to 24 Months after Liver Transplant: Association with Pretransplant Psychosocial Factors and Perceptions of Health Status Change","volume":"23","author":"Rodrigue","year":"2013","journal-title":"Prog. Transplant."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/13548500600780465","article-title":"How Does Psychological Processing Relate to Compliance Behaviour after Lung Transplantation? A Content Analytical Study","volume":"12","author":"Goetzmann","year":"2007","journal-title":"Psychol. Health Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1399-0012.2011.01431.x","article-title":"Stress and Coping in Caregivers of Patients Awaiting Solid Organ Transplantation","volume":"26","author":"Goetzinger","year":"2012","journal-title":"Clin. Transplant."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.27422","article-title":"Predictors of Poor Mental and Physical Health Status among Patients with Chronic Hepatitis C Infection: The Chronic Hepatitis Cohort Study (CHeCS)","volume":"61","author":"Boscarino","year":"2015","journal-title":"Hepatology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.3389\/fpsyg.2019.02304","article-title":"Psychosocial Support in Liver Transplantation: A Dyadic Study with Patients and Their Family Caregivers","volume":"10","author":"Cipolletta","year":"2019","journal-title":"Front. Psychol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/4\/1014\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:58:03Z","timestamp":1760104683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/4\/1014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":124,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["jcm13041014"],"URL":"https:\/\/doi.org\/10.3390\/jcm13041014","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]}}}